Benjamin Edwards Inc Bristol Myers Squibb CO Transaction History

Benjamin Edwards Inc

$503 Million
Q1 2024

A detailed history of Benjamin Edwards Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Benjamin Edwards Inc holds 264 shares of BMY stock, worth $10,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares

264

Previous 96 175.0%

Holding current value

$10,787

Previous $5,000 180.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$47.98 - $54.4 $8,060 - $9,139	168 Added 175.0%	264 $14,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $260,099 - $290,831	-4,493 Reduced 97.91%	96 $6,000
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $127 - $141	-2 Reduced 0.04%	4,589 $293,000
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $52,305 - $59,325	796 Added 20.97%	4,591 $318,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $19,516 - $23,110	285 Added 8.12%	3,795 $273,000

Q3 2022 Oct 28, 2022	SELL	$0.13 - $76.84 $680 - $401,950	-5,231 Reduced 59.84%	3,510 $250,000
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $375,372 - $413,416	5,169 Added 144.71%	8,741 $673,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $39,839 - $47,770	648 Added 22.16%	3,572 $261,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $104,256 - $121,538	1,944 Added 198.37%	2,924 $182,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $22,721 - $26,615	384 Added 64.43%	980 $58,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $2,785 - $3,033	45 Added 8.17%	596 $40,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $8,129 - $9,143	137 Added 33.09%	551 $35,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $574 - $636	10 Added 2.48%	414 $25,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $9,867 - $11,536	-180 Reduced 30.82%	404 $24,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $278 - $404	-6 Reduced 1.02%	584 $33,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $7,086 - $9,243	144 Added 32.29%	590 $38,000
Q3 2019 Nov 05, 2019	BUY	$42.77 - $50.71 $13,344 - $15,821	312 Added 232.84%	446 $23,000
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $2,364 - $2,615	53 Added 65.43%	134 $6,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $3,654 - $4,357	81 New	81 $4,000

Others Institutions Holding BMY

# of Institutions

2,557

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Bristol Myers Squibb CO Transaction History